 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease |
| Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, Roger D. Hurst, Neil H. Hyman, Atsushi Sakuraba, Joel Pekow, Sushila Dalal, Russell D. Cohen, Bruno Pereira, David T. Rubin |
|
Intest Res. 2022;20(3):303-312. Published online August 4, 2021 DOI: https://doi.org/10.5217/ir.2021.00018 |
|
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease Intestinal Research. 2022;20(3):303-312  Anti–Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery Clinical Gastroenterology and Hepatology. 2014;12(9):1503-1506 Anti–Tumor Necrosis Factor Antibodies for Prevention of Crohn’s Disease Recurrence After Surgery: More Than a Hope Clinical Gastroenterology and Hepatology. 2015;13(10):1856 P502 Tumour necrosis factor antagonists are superior to anti-integrin and anti-IL-12/23 therapies for preventing postoperative recurrence in adult Crohn’s disease patients requiring postoperative therapy Journal of Crohn's and Colitis. 2020;14(Supplement_1):S436-S437 Anti-Tumor Necrosis Factor Nonresponders in Crohn’s Disease: Therapeutic Strategies Digestive Diseases. 2009;27(3):351-357 Postoperative Anti-TNF Therapy in the Management of Crohn's Disease Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;201-205 A159 ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN’S DISEASE AND LUMINAL CROHN’S DISEASE: A COMPARATIVE COHORT STUDY Journal of the Canadian Association of Gastroenterology. 2021;4(Supplement_1):166-167 Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn’s disease following ileocolonic resection International Journal of Colorectal Disease. 2016;31(11):1751-1758 Therapeutic Drug Monitoring Increases Drug Retention of Anti–Tumor Necrosis Factor Alpha Agents in Pediatric Patients With Crohn’s Disease Inflammatory Bowel Diseases. 2019; Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence Gut and Liver. 2022;16(3):414-422 |
